Kadakkal Radhakrishnan, MD

Appointed
2006

Education & Fellowships

Fellowship - Cleveland Clinic
Pediatric Gastroenterology
Cleveland, OH United States
2006

Residency - Cleveland Clinic
Pediatrics
Cleveland, OH
2003

Residency - Medical College, University of Kerala
Pediatrics
Kerala,
1995

Medical Education - Medical College, University of Kerala
Kerala,
1992

Additional Training

• Pediatric Residency, S.A.T. Hospital, Trivandrum, Kerala, India, 1992-1995
• Pediatric Training, Royal College of Physicians, U.K; Training at Leicester Teaching Hospital Rotation, 3 years, and at Slough District Hospital,1 year; 1996-2000

Professional Highlights

• Medical Director, Nutritional Support and Intestinal Rehabilitation, Children's Hospital, Cleveland Clinic
• Assistant Professor of Pediatrics, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
• Cyclic Vomiting Clinic, Cleveland Clinic; third clinic in the nation for this disorder for children. Dr. Radhakrishnan runs clinic in conjunction with Dr. Sumit Parikh, Pediatric Neurology, Cleveland Clinic.

Certifications

• Pediatrics - Pediatric Transplant Hepatology
• Pediatrics - Pediatric Gastroenterology

Specialty Interests

Chronic pancreatitis, cyclic vomiting, diagnostic and therapeutic endoscopy, Intestinal failure and small bowel rehabilitation in children, liver disorders in children and care of liver transplant patients, metabolic disorders - GI problems in metabolic disorders and liver related metabolic problems, including Glycogen Storage Disease

Awards & Honors

• Best Doctor, Pediatric Gastroenterology, 2009 onwards
• America's Top Gastroenterologists, Consumers' Research Council of America, 2006 onwards
• Staff Teacher of the Year, voted by pediatric residents, Cleveland Clinic, 2007

Memberships

• American College of Gastroenterology
• American Gastroenterological Association
• American Association for Study of Liver Disease
• Permanent Registration, State Medical Board of Ohio

See publications for Kadakkal Radhakrishnan, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/7/2024, Dr. Radhakrishnan has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.